Post-transcriptional RNA regulation in mammalian neural stem cells

哺乳动物神经干细胞的转录后RNA调控

基本信息

  • 批准号:
    9317830
  • 负责人:
  • 金额:
    $ 19.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-04-01 至 2019-03-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT This goal of this R21 proposal is to uncover post-transcriptional mechanisms important for neural progenitors of the developing brain, by focusing on the RNA binding protein, Rbm8a. RBM8A copy number variations are associated with intellectual disability, autism, microcephaly and macrocephaly. RBM8A mutations cause TAR syndrome, a rare blood and bone disorder which can also present with neurodevelopmental deficits. These neurodevelopmental pathologies can arise from aberrant neurogenesis of the cerebral cortex, in which neurons are produced from proliferating neural progenitors. Indeed, our lab has discovered that neural progenitor- specific Rbm8a haploinsufficiency in mice disrupts progenitor function and neurogenesis, which ultimately causes microcephaly. Rbm8a, together with Magoh and Eif4a3, form the exon junction complex, which binds spliced mRNAs to mediate key aspects of mRNA metabolism including translation. Together these findings demonstrate Rbm8a may influence disease by disrupting neurogenesis. However, our understanding of molecular mechanisms by which Rbm8a impacts brain development is limited to just a few candidates. In this proposal, we will test the central hypothesis that Rbm8a binds to and promotes translation of transcripts relevant for neural progenitor proliferation. First we will identify direct targets of Rbm8a in neuroepithelial progenitors, using a novel RNA immunoprecipitation-based approach in vivo. Second, we will use biochemical approaches to discover Rbm8a translational targets in neuroepithelial progenitors. Our proposal is built upon strong preliminary data, including the discovery of transcriptome-wide changes in Rbm8a hapoloinsufficient neuroepithelial progenitors. Successfully completed, these aims will provide new insights into how neural progenitors regulate fate decisions in the developing brain under both normal and pathological settings. Because RBM8A mutation is associated with neurodevelopmental disorders, these studies promise to provide important molecular insights into how mutations in this gene influence disease pathology.
摘要 这个R21建议的目标是揭示神经祖细胞重要的转录后机制 通过关注RNA结合蛋白Rbm 8a,RBM 8A拷贝数变异是 与智力残疾、自闭症、小头症和大头症有关。RBM 8A突变导致TAR 综合征,一种罕见的血液和骨骼疾病,也可以表现为神经发育缺陷。这些 神经发育病理学可由大脑皮层的异常神经发生引起,其中神经元 是由增殖的神经祖细胞产生的实际上,我们的实验室已经发现神经祖细胞- 小鼠中特异性Rbm 8a单倍不足破坏了祖细胞功能和神经发生,最终 导致小头畸形。Rbm 8a与Magoh和Eif 4a 3一起形成外显子连接复合物,其结合 剪接的mRNA介导mRNA代谢的关键方面,包括翻译。这些发现 Rbm 8a可能通过破坏神经发生来影响疾病。然而,我们对 Rbm 8a影响大脑发育的分子机制仅限于少数候选者。在这 建议,我们将测试中心假设,Rbm 8a结合并促进转录本的翻译 与神经祖细胞增殖有关。首先,我们将确定Rbm 8a在神经上皮细胞中的直接靶点。 祖细胞,使用一种新的RNA免疫沉淀为基础的方法在体内。其次,我们将使用生物化学 发现神经上皮祖细胞中Rbm 8a翻译靶点的方法。我们的建议是建立在 强有力的初步数据,包括发现Rbm 8a单倍体的全转录组变化, 神经上皮祖细胞。成功完成,这些目标将提供新的见解如何神经 在正常和病理情况下,祖细胞调节发育中的脑中的命运决定。 由于RBM 8A突变与神经发育障碍有关,这些研究有望提供 重要的分子见解如何在这个基因的突变影响疾病的病理。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Debra Silver其他文献

Debra Silver的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Debra Silver', 18)}}的其他基金

Roles for uniquely human enhancers in brain development and WNT signaling
人类独特的增强子在大脑发育和 WNT 信号传导中的作用
  • 批准号:
    10577092
  • 财政年份:
    2023
  • 资助金额:
    $ 19.88万
  • 项目类别:
Dynamic control of cortical development and disease by mRNA stability
通过 mRNA 稳定性动态控制皮质发育和疾病
  • 批准号:
    10510361
  • 财政年份:
    2022
  • 资助金额:
    $ 19.88万
  • 项目类别:
Cell biological and proteomic investigation of pathogenic DDX3X missense mutations during neurogenesis
神经发生过程中致病性 DDX3X 错义突变的细胞生物学和蛋白质组学研究
  • 批准号:
    10313796
  • 财政年份:
    2021
  • 资助金额:
    $ 19.88万
  • 项目类别:
Cell biological and proteomic investigation of pathogenic DDX3X missense mutations during neurogenesis
神经发生过程中致病性 DDX3X 错义突变的细胞生物学和蛋白质组学研究
  • 批准号:
    10474429
  • 财政年份:
    2021
  • 资助金额:
    $ 19.88万
  • 项目类别:
Distal mRNA localization and translation in neural stem cells of the developing brain
发育中大脑的神经干细胞中的远端 mRNA 定位和翻译
  • 批准号:
    10435490
  • 财政年份:
    2018
  • 资助金额:
    $ 19.88万
  • 项目类别:
Distal mRNA localization and translation in neural stem cells of the developing brain
发育中大脑的神经干细胞中的远端 mRNA 定位和翻译
  • 批准号:
    10188661
  • 财政年份:
    2018
  • 资助金额:
    $ 19.88万
  • 项目类别:
Mechanisms of neural progenitor division in the developing brain
大脑发育中神经祖细胞分裂的机制
  • 批准号:
    8858697
  • 财政年份:
    2013
  • 资助金额:
    $ 19.88万
  • 项目类别:
Essential requirements of Eif4a3 in brain development and disease
Eif4a3 在大脑发育和疾病中的基本需求
  • 批准号:
    10178122
  • 财政年份:
    2013
  • 资助金额:
    $ 19.88万
  • 项目类别:
Mechanisms of neural progenitor division in the developing brain
大脑发育中神经祖细胞分裂的机制
  • 批准号:
    8665501
  • 财政年份:
    2013
  • 资助金额:
    $ 19.88万
  • 项目类别:
Mechanisms of neural progenitor division in the developing brain
大脑发育中神经祖细胞分裂的机制
  • 批准号:
    9285615
  • 财政年份:
    2013
  • 资助金额:
    $ 19.88万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 19.88万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.88万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 19.88万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.88万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 19.88万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 19.88万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.88万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 19.88万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 19.88万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.88万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了